OX40 (CD134) and OX40 ligand, important immune checkpoints in cancer
Juan Deng,1,2 Sha Zhao,1,2 Xiaoshen Zhang,1,2 Keyi Jia,1,2 Hao Wang,1,2 Caicun Zhou,1 Yayi He1 1Department of Medical Oncology, Shanghai Pulmonary Hospital, Tongji University Medical School Cancer Institute, Tongji University School of Medicine,...
Main Authors: | , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2019-09-01
|
Series: | OncoTargets and Therapy |
Subjects: | |
Online Access: | https://www.dovepress.com/ox40-cd134-and-ox40-ligand-important-immune-checkpoints-in-cancer-peer-reviewed-article-OTT |